Cargando…
Breast cancer in young women and its impact on reproductive function
BACKGROUND: Breast cancer is the most common cancer in women in developed countries, and 12% of breast cancer occurs in women 20–34 years. Survival from breast cancer has significantly improved, and the potential late effects of treatment and the impact on quality of life have become increasingly im...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667113/ https://www.ncbi.nlm.nih.gov/pubmed/19174449 http://dx.doi.org/10.1093/humupd/dmn064 |
_version_ | 1782166092861407232 |
---|---|
author | Hickey, M. Peate, M. Saunders, C.M. Friedlander, M. |
author_facet | Hickey, M. Peate, M. Saunders, C.M. Friedlander, M. |
author_sort | Hickey, M. |
collection | PubMed |
description | BACKGROUND: Breast cancer is the most common cancer in women in developed countries, and 12% of breast cancer occurs in women 20–34 years. Survival from breast cancer has significantly improved, and the potential late effects of treatment and the impact on quality of life have become increasingly important. Young women constitute a minority of breast cancer patients, but commonly have distinct concerns and issues compared with older women, including queries regarding fertility, contraception and pregnancy. Further, they are more likely than older women to have questions regarding potential side effects of therapy and risk of relapse or a new primary. In addition, many will have symptoms associated with treatment and they present a management challenge. Reproductive medicine specialists and gynaecologists commonly see these women either shortly after initial diagnosis or following adjuvant therapy and should be aware of current management of breast cancer, the options for women at increased genetic risk, the prognosis of patients with early stage breast cancer and how adjuvant systemic treatments may impact reproductive function. METHODS: No systematic literature search was done. The review focuses on the current management of breast cancer in young women and the impact of treatment on reproductive function and subsequent management. With reference to key studies and meta-analyses, we highlight controversies and current unanswered questions regarding patient management. RESULTS: Chemotherapy for breast cancer is likely to negatively impact on reproductive function. A number of interventions are available which may increase the likelihood of future successful pregnancy, but the relative safety of these interventions is not well established. For those who do conceive following breast cancer, there is no good evidence that pregnancy is detrimental to survival. We review current treatment; effects on reproductive function; preservation of fertility; contraception; pregnancy; breastfeeding and management of menopausal symptoms following breast cancer. CONCLUSION: This paper provides an update on the management of breast cancer in young women and is targeted at reproductive medicine specialists and gynaecologists. |
format | Text |
id | pubmed-2667113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26671132009-04-13 Breast cancer in young women and its impact on reproductive function Hickey, M. Peate, M. Saunders, C.M. Friedlander, M. Hum Reprod Update Reviews BACKGROUND: Breast cancer is the most common cancer in women in developed countries, and 12% of breast cancer occurs in women 20–34 years. Survival from breast cancer has significantly improved, and the potential late effects of treatment and the impact on quality of life have become increasingly important. Young women constitute a minority of breast cancer patients, but commonly have distinct concerns and issues compared with older women, including queries regarding fertility, contraception and pregnancy. Further, they are more likely than older women to have questions regarding potential side effects of therapy and risk of relapse or a new primary. In addition, many will have symptoms associated with treatment and they present a management challenge. Reproductive medicine specialists and gynaecologists commonly see these women either shortly after initial diagnosis or following adjuvant therapy and should be aware of current management of breast cancer, the options for women at increased genetic risk, the prognosis of patients with early stage breast cancer and how adjuvant systemic treatments may impact reproductive function. METHODS: No systematic literature search was done. The review focuses on the current management of breast cancer in young women and the impact of treatment on reproductive function and subsequent management. With reference to key studies and meta-analyses, we highlight controversies and current unanswered questions regarding patient management. RESULTS: Chemotherapy for breast cancer is likely to negatively impact on reproductive function. A number of interventions are available which may increase the likelihood of future successful pregnancy, but the relative safety of these interventions is not well established. For those who do conceive following breast cancer, there is no good evidence that pregnancy is detrimental to survival. We review current treatment; effects on reproductive function; preservation of fertility; contraception; pregnancy; breastfeeding and management of menopausal symptoms following breast cancer. CONCLUSION: This paper provides an update on the management of breast cancer in young women and is targeted at reproductive medicine specialists and gynaecologists. Oxford University Press 2009 2009-01-27 /pmc/articles/PMC2667113/ /pubmed/19174449 http://dx.doi.org/10.1093/humupd/dmn064 Text en © The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/2.0/uk/ The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org |
spellingShingle | Reviews Hickey, M. Peate, M. Saunders, C.M. Friedlander, M. Breast cancer in young women and its impact on reproductive function |
title | Breast cancer in young women and its impact on reproductive function |
title_full | Breast cancer in young women and its impact on reproductive function |
title_fullStr | Breast cancer in young women and its impact on reproductive function |
title_full_unstemmed | Breast cancer in young women and its impact on reproductive function |
title_short | Breast cancer in young women and its impact on reproductive function |
title_sort | breast cancer in young women and its impact on reproductive function |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667113/ https://www.ncbi.nlm.nih.gov/pubmed/19174449 http://dx.doi.org/10.1093/humupd/dmn064 |
work_keys_str_mv | AT hickeym breastcancerinyoungwomenanditsimpactonreproductivefunction AT peatem breastcancerinyoungwomenanditsimpactonreproductivefunction AT saunderscm breastcancerinyoungwomenanditsimpactonreproductivefunction AT friedlanderm breastcancerinyoungwomenanditsimpactonreproductivefunction |